Evaluation of e-Lung automated quantitative computed tomography biomarkers in idiopathic pulmonary fibrosis

Background In patients with idiopathic pulmonary fibrosis (IPF) there is a need to identify biomarkers that 1) are associated with increased risk of adverse outcome and 2) can be used to monitor treatment response or identify disease progression over time. Methods Two consecutive cohorts of patients...

Full description

Bibliographic Details
Published in:ERJ Open Research
Main Author: George P.M.; Rennison-Jones C.; Benvenuti G.; Sifostratoudaki A.; Ottink F.A.; Bou-Zeid W.; Ledda R.E.; Abul Kadir R.F.; Johari B.; Fernandez C.; Harston G.W.J.; Joly O.; Gerry S.; Devaraj A.
Format: Article
Language:English
Published: European Respiratory Society 2024
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85211349800&doi=10.1183%2f23120541.00570-2024&partnerID=40&md5=5288db6846ea8f9b950fb88d047d289c